Lv1
80 积分 2022-06-14 加入
Multiple myeloma
16天前
已完结
The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
16天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
17天前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
26天前
已完结
Talquetamab: First Approval
26天前
已完结
Belantamab Mafodotin: First Approval
29天前
已完结
Activation of B-Cell Maturation Antigen (BCMA) on Human Multiple Myeloma Cells by a Proliferation-Inducing Ligand (APRIL) Promotes Myeloma Cell Function in the Bone Marrow Microenvironment
29天前
已关闭
Dual-antigen-targeting T-cell immunotherapies in MM: circumventing tumor heterogeneity and preventing antigen escape
1个月前
已完结
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma
1个月前
已关闭
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
1个月前
已完结
皖公网安备34019202002308